Download - Leptospirosis : update on management
![Page 1: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/1.jpg)
LEPTOSPIROSIS UPDATEDr Vasif MCGMKMCH
![Page 2: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/2.jpg)
• Zoonotic disease
• Caused by the spirochete Leptospira
• Historically known as Weil’s disease
• Described in 1885 by Adolf Weil with clinical hallmarks of
splenomegaly jaundice nephritis
INTRODUCTION
![Page 3: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/3.jpg)
SYNONYMS
![Page 4: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/4.jpg)
THE CAUSATIVE BACTERIUMOrder Spirochaetales – Treponema, Borrelia, Leptospira
Family – Leptospiraceae, susceptible to heat, acid
Genus – Leptospira, 26 serogroups, 250 serovars
Pathogenic: Interrogans, Nonpathogenic: biflex
Corkscrew shaped, delicate, flexible spirochete, Gram -ve
thick, coiled, flagellate, actively motile
![Page 5: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/5.jpg)
EPIDEMIOLOGY
• Incidence of Leptospirosis in developing countries is 10 - 100/1,00,000 cases/year• Only four states (Kerala,Gujarat, Tamilnadu & Maharashtra) report more
than 500 cases per year• Incidence of Leptospirosis is 50 – 65 cases /100,000 per year in Andaman
and Nicobar Islands • Prevalence rate of Leptospirosis reported
• 38.1% from Calicut• 52.7% from Andaman and Nicobar Islands• 32.9% from Chennai (data from asymptomatic persons detected during sero surveys)
• Leptospirosis is grossly under reported because of lack of awareness of the disease and non availability of diagnostic tests• Last outbreak reported in Mumbai during 2015
![Page 6: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/6.jpg)
LIFE CYCLE
![Page 7: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/7.jpg)
![Page 8: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/8.jpg)
![Page 9: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/9.jpg)
![Page 10: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/10.jpg)
PATHOGENESIS
![Page 11: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/11.jpg)
![Page 12: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/12.jpg)
![Page 13: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/13.jpg)
•Clinical expression can beSubclinical infectionUndifferentiated febrile illnessWeil’s disease
• Incubation period 2-30 days (average 5-14 days)
CLINICAL FEATURES
![Page 14: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/14.jpg)
![Page 15: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/15.jpg)
• The most severe form of leptospirosis• Monophasic and fulminant• Variable combinations of jaundice, acute kidney
injury, hypotension and hemorrhage
• Pulmonary hemorrhage is the most common• Multisystem involvement occurs
WEIL’S DISEASE
![Page 16: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/16.jpg)
![Page 17: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/17.jpg)
![Page 18: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/18.jpg)
•High index of suspicion is critical in a setting ofAn appropriate exposure historyInfection’s protean manifestations
• Biochemical, hematological and urinalysis may suggest but are not specific for diagnosis
DIAGNOSIS
![Page 19: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/19.jpg)
LABORATORY TESTS
• TC / DC / ESR / Hb / Platelet count LEUCOCYTOSIS/THROMBOCYTOPENIA• Serum Bilirubin / SGOT/ SGPT / SAP• Blood Urea, Creatinine & Electrolytes HYPOKALEMIA/HYPOMAGNESEMIA• Chest X-Ray; ECG• Tests for diagnosis of Leptospirosis
• Culture for Leptospira• MAT; Sero conversion or 4 fold rise/ high titer• ELISA / MSAT• PCR
• MAT: Microscopic agglutination test• (M)SAT: Microscopic slide agglutination Test
![Page 20: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/20.jpg)
Dark field microscopy showing Leptospira spp.
![Page 21: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/21.jpg)
MAT INTERPRETATION• Titres peak late (2nd or 3rd week) but persist longer ( 5 to 10
years)• Less sensitive,Repeat samples needed• Single titre 1:100 significant criteria
• Endemic area 1:400• Non endemic area 1:100, 1:200• Serosurvey 1:50
• Repeat titre four fold rise / seroconversion
![Page 22: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/22.jpg)
• Leptospires can be cultured from blood and CSF during first 7-10 days
•Urine culture useful beginning in the 2nd week
•May take 2-4 weeks to be positive
•Urine cultures can remain positive for many months/years despite therapy
ISOLATION
![Page 23: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/23.jpg)
GUIDELINES TO DIAGNOSE
LEPTOSPIROSIS
•INDIAN GUIDELINES•WHO GUIDELINES
![Page 24: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/24.jpg)
![Page 25: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/25.jpg)
![Page 26: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/26.jpg)
![Page 27: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/27.jpg)
![Page 28: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/28.jpg)
• Malaria• Enteric fever• Dengue/ chikungunya• Hanta virus infection• Viral hepatitis• Influenza• Rickettsial diseases
DIFFERENTIAL DIAGNOSIS
![Page 29: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/29.jpg)
![Page 30: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/30.jpg)
TREATMENT
![Page 31: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/31.jpg)
SUPORTIVE TREATMENT
• Methyl Prednisolone at 1 gm daily IV for 3 days, followed by oral prednisolone at 1 mg/kg for 7 days offered benefit if given within 12 h of the onset of pulmonary manifestations
![Page 32: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/32.jpg)
COMPLICATIONS
• Jaundice
• AKI
• Pulmonary hemorrhage
• ARDS
• Neuroleptospirosis
• Hypotension
• Thrombocytopenia
• Myocarditis
• Ocular complications
• Hypokalemic paralysis
![Page 33: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/33.jpg)
LEPTOSPIROSIS IN PREGNANCY
• Fetal loss high in 1st trimester and near term mothers
• Congenital infections are rare and long-term serious effects have not been documented.• Hence, leptospirosis acquired in pregnancy is not an indication for its
termination• AMPICILLIN 500mg 6th hourly should be given
LEPTOSPIROSIS IN HIV• recovery slower than is usual for leptospirosis• residual renal impairment likely
![Page 34: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/34.jpg)
LEPTOSPIROSIS WITH CONCOMITANT ILLNESS
• It is important to look for alternative infections in an appropriate setting particularly if the patient does not show clinical signs of improvement despite pathogen-directed therapy for leptospirosis as dual infections like
• DENGUE• HEPATITIS E• SCRUB TYPHUS• MALARIACan coexist concurrently
![Page 35: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/35.jpg)
PREVENTION
![Page 36: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/36.jpg)
![Page 37: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/37.jpg)
CHEMOPROPHYLAXIS
![Page 38: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/38.jpg)
VACCINE ???
•No vaccine is yet available for use in humans with proven benefit..
![Page 39: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/39.jpg)
![Page 40: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/40.jpg)
![Page 41: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/41.jpg)
TAKE HOME MESSAGES
• Leptospirosis has a spectrum of clinical presentations, with a biphasic natural history.• Major systemic complications occur during the immune phase of the disease, which is
usually 5–10 days after infection.
• 2 major symptoms : fever and myalgia +/- Jaundice• 2 major signs : conjunctival suffusion and muscle tenderness
• Choice of diagnostic testing relies on accurate prediction of the infection. Acute disease is best detected by culture or PCR, and immune phase disease by serology.
• reducing the incidence of leptospirosis can be achieved by promoting the ‘cover-wash-clean up’ strategies to at risk individuals to reduce contact with infected animals or materials
![Page 42: Leptospirosis : update on management](https://reader036.vdocuments.net/reader036/viewer/2022062503/589a9c3a1a28abfc1a8b49fb/html5/thumbnails/42.jpg)